Hello, my name is Andrea Alms. I'm technology investor and financial manager and this is your money in motion. Investment trends remain focused on assets centric approaches, particularly favoring advanced clinical assets over platform inventions investments. The enthusiasm for AI application and drug discovery and development persist, but investors are increasingly aware of the extended timeline for realizing AI potential in pharma.
First, the first M&A in the AI biotech space was excited to r